Target intelligence / Profile preview

Torsin family 2 member A (TOR2A)

Target
TOR2A
Molecular classification
AAA+ ATPase, Chaperone-like protein, Protein processing (not a receptor, channel, or classical enzyme; functionally a molecular chaperone in the AAA+ protein superfamily)
01

Overview

Torsin family 2 member A (TOR2A) encodes a member of the AAA+ (ATPases Associated with diverse cellular Activities) superfamily, sharing structural features with Clp proteases and heat shock proteins[1][2][4][5]. TOR2A is predominantly localized to the endoplasmic reticulum and perinuclear space, where it likely acts as a chaperone-like ATPase, facilitating protein remodeling and intracellular transport processes[2][5]. Unique transcript variants of TOR2A generate precursor proteins yielding the bioactive peptides salusin-alpha and salusin-beta (collectively, "salusins"), which have established endocrine and paracrine effects, including potent hypotensive and mitogenic actions and roles in cardiovascular homeostasis and potentially atherosclerosis[1][4]. A pathogenic variant in TOR2A has been associated with familial blepharospasm, implicating this molecule in neuronal health and dystonia[1][4]. Although TOR2A is biologically important—regulating protein homeostasis and generating regulatory peptides—it is not classified as a direct therapeutic target and currently has no known small-molecule ligands or pharmacological modulators[1][4].

Other names
Torsin-2ATorsin-related protein 1TORP1ProsalusinSalusin-alphaSalusin-betaHEMBA1005096PSEC0218UNQ6408/PRO21181FLJ14771
02

Mechanism of action

Not applicable (no known direct pharmacological targeting); functional roles are primarily through protein interactions, not as a classical drug target

03

Biological functions

Protein processingProtein remodelingIntracellular transportRegulation of cellular stress responseModulation of peptide hormone precursors (via salusins)Potential roles in signaling cascades
04

Disease associations

Neurodegenerative disease (specifically movement disorders such as blepharospasm/dystonia)Cardiovascular disease (through effects of salusins on vascular biology)Atherosclerosis
05

Biomarkers

Mutations, e.g., p.Arg190Cys variant linked to heritable blepharospasm (dystonia subtype)altered salusin levels may serve as exploratory biomarkers for vascular dysfunction

Beyond the preview

Go deeper on Torsin family 2 member A (TOR2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torsin family 2 member A (TOR2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call